“Intermediate Results of the Prospective Randomized Controlled Trial VOG-01: ‘Evaluation of the Efficacy of Neoadjuvant Combination Hormone Therapy in Premenopausal Patients With ER+ HER2- Breast Cancer’”. Voprosy onkologii 68, no. 3 (July 6, 2022): 354–361. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1468.